Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
ID_report: ID of the individual that can be publically shared, e.g. as listed in a publication
Reference: reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, incl. link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
Remarks: remarks about the individual
Gender: gender individual
All options:
- ? = unknown
- - = not applicable
- F = female
- M = male
- rF = raised as female
- rM = raised as male
Consanguinity: indicates whether the parents are related (consanguineous), not related (non-consanguineous) or whether consanguinity is not known (unknown)
All options:
- no = non-consanguineous parents
- yes = consanguineous parents
- likely = consanguinity likely
- ? = unknown
- - = not applicable
Country: where (country) does the individual live/recently came from. Give additional details (population, specific sub-group) and when parents come from different countries in "Population". Belgium = individual lives in/recently came from Belgium, (France) = reported by laboratory in France, individual's country of origin not sure
All options:
- ? (unknown)
- - (not applicable)
- Afghanistan
- (Afghanistan)
- Albania
- (Albania)
- Algeria
- (Algeria)
- American Samoa
- (American Samoa)
- Andorra
- (Andorra)
- Angola
- (Angola)
- Anguilla
- (Anguilla)
- Antarctica
- (Antarctica)
- Antigua and Barbuda
- (Antigua and Barbuda)
- Argentina
- (Argentina)
- Armenia
- (Armenia)
- Aruba
- (Aruba)
- Australia
- (Australia)
- Austria
- (Austria)
- Azerbaijan
- (Azerbaijan)
- Bahamas
- (Bahamas)
- Bahrain
- (Bahrain)
- Bangladesh
- (Bangladesh)
- Barbados
- (Barbados)
- Belarus
- (Belarus)
- Belgium
- (Belgium)
- Belize
- (Belize)
- Benin
- (Benin)
- Bermuda
- (Bermuda)
- Bhutan
- (Bhutan)
- Bolivia
- (Bolivia)
- Bosnia and Herzegovina
- (Bosnia and Herzegovina)
- Botswana
- (Botswana)
- Bouvet Island
- (Bouvet Island)
- Brazil
- (Brazil)
- British Indian Ocean Territory
- (British Indian Ocean Territory)
- Brunei Darussalam
- (Brunei Darussalam)
- Bulgaria
- (Bulgaria)
- Burkina Faso
- (Burkina Faso)
- Burundi
- (Burundi)
- Cambodia
- (Cambodia)
- Cameroon
- (Cameroon)
- Canada
- (Canada)
- Cape Verde
- (Cape Verde)
- Cayman Islands
- (Cayman Islands)
- Central African Republic
- (Central African Republic)
- Central Europe
- Chad
- (Chad)
- Chile
- (Chile)
- China
- (China)
- Christmas Island
- (Christmas Island)
- Cocos (Keeling Islands)
- (Cocos (Keeling Islands))
- Colombia
- (Colombia)
- Comoros
- (Comoros)
- Congo
- (Congo)
- Cook Islands
- (Cook Islands)
- Costa Rica
- (Costa Rica)
- Cote D'Ivoire (Ivory Coast)
- (Cote D'Ivoire (Ivory Coast))
- Croatia (Hrvatska)
- (Croatia (Hrvatska))
- Cuba
- (Cuba)
- Cyprus
- (Cyprus)
- Czech Republic
- (Czech Republic)
- Denmark
- (Denmark)
- Djibouti
- (Djibouti)
- Dominica
- (Dominica)
- Dominican Republic
- (Dominican Republic)
- East Timor
- (East Timor)
- Ecuador
- (Ecuador)
- Egypt
- (Egypt)
- El Salvador
- (El Salvador)
- England
- (England)
- Equatorial Guinea
- (Equatorial Guinea)
- Eritrea
- (Eritrea)
- Estonia
- (Estonia)
- Ethiopia
- (Ethiopia)
- Falkland Islands (Malvinas)
- (Falkland Islands (Malvinas))
- Faroe Islands
- (Faroe Islands)
- Fiji
- (Fiji)
- Finland
- (Finland)
- France
- (France)
- Gabon
- (Gabon)
- Gambia
- (Gambia)
- Georgia
- (Georgia)
- Germany
- (Germany)
- Ghana
- (Ghana)
- Gibraltar
- (Gibraltar)
- Greece
- (Greece)
- Greenland
- (Greenland)
- Grenada
- (Grenada)
- Guadeloupe
- (Guadeloupe)
- Guam
- (Guam)
- Guatemala
- (Guatemala)
- Guiana, French
- (Guiana, French)
- Guinea
- (Guinea)
- Guinea-Bissau
- (Guinea-Bissau)
- Guyana
- (Guyana)
- Haiti
- (Haiti)
- Heard and McDonald Islands
- (Heard and McDonald Islands)
- Honduras
- (Honduras)
- Hong Kong
- (Hong Kong)
- Hungary
- (Hungary)
- Iceland
- (Iceland)
- India
- (India)
- Indonesia
- (Indonesia)
- Iran
- (Iran)
- Iraq
- (Iraq)
- Ireland
- (Ireland)
- Israel
- (Israel)
- Italy
- (Italy)
- Jamaica
- (Jamaica)
- Japan
- (Japan)
- Jordan
- (Jordan)
- Kazakhstan
- (Kazakhstan)
- Kenya
- (Kenya)
- Kiribati
- (Kiribati)
- Korea
- (Korea)
- Korea, North (People's Republic)
- (Korea, North (People's Republic))
- Korea, South (Republic)
- (Korea, South (Republic))
- Kosovo
- (Kosovo)
- Kuwait
- (Kuwait)
- Kyrgyzstan (Kyrgyz Republic)
- (Kyrgyzstan (Kyrgyz Republic))
- Laos
- (Laos)
- Latvia
- (Latvia)
- Lebanon
- (Lebanon)
- Lesotho
- (Lesotho)
- Liberia
- (Liberia)
- Libya
- (Libya)
- Liechtenstein
- (Liechtenstein)
- Lithuania
- (Lithuania)
- Luxembourg
- (Luxembourg)
- Macau
- (Macau)
- Macedonia
- (Macedonia)
- Madagascar
- (Madagascar)
- Malawi
- (Malawi)
- Malaysia
- (Malaysia)
- Maldives
- (Maldives)
- Mali
- (Mali)
- Mallorca
- (Mallorca)
- Malta
- (Malta)
- Marshall Islands
- (Marshall Islands)
- Martinique
- (Martinique)
- Mauritania
- (Mauritania)
- Mauritius
- (Mauritius)
- Mayotte
- (Mayotte)
- Mexico
- (Mexico)
- Micronesia
- (Micronesia)
- Moldova
- (Moldova)
- Monaco
- (Monaco)
- Mongolia
- (Mongolia)
- Montserrat
- (Montserrat)
- Morocco
- (Morocco)
- Mozambique
- (Mozambique)
- Myanmar
- (Myanmar)
- Namibia
- (Namibia)
- Nauru
- (Nauru)
- Nepal
- (Nepal)
- Netherlands
- (Netherlands)
- Netherlands Antilles
- (Netherlands Antilles)
- Neutral Zone (Saudia Arabia/Iraq)
- (Neutral Zone (Saudia Arabia/Iraq))
- New Caledonia
- (New Caledonia)
- New Zealand
- (New Zealand)
- Nicaragua
- (Nicaragua)
- Niger
- (Niger)
- Nigeria
- (Nigeria)
- Niue
- (Niue)
- Norfolk Island
- (Norfolk Island)
- Northern Ireland
- (Northern Ireland)
- Northern Mariana Islands
- (Northern Mariana Islands)
- Norway
- (Norway)
- Oman
- (Oman)
- Pakistan
- (Pakistan)
- Palau
- (Palau)
- Palestine
- (Palestine)
- Panama
- (Panama)
- Papua New Guinea
- (Papua New Guinea)
- Paraguay
- (Paraguay)
- Peru
- (Peru)
- Philippines
- (Philippines)
- Pitcairn
- (Pitcairn)
- Poland
- (Poland)
- Polynesia, French
- (Polynesia, French)
- Portugal
- (Portugal)
- Puerto Rico
- (Puerto Rico)
- Qatar
- (Qatar)
- Reunion
- (Reunion)
- Romania
- (Romania)
- Russia
- (Russia)
- Russian Federation
- (Russian Federation)
- Rwanda
- (Rwanda)
- S. Georgia and S. Sandwich Isls.
- (S. Georgia and S. Sandwich Isls.)
- Saint Kitts and Nevis
- (Saint Kitts and Nevis)
- Saint Lucia
- (Saint Lucia)
- Saint Vincent and The Grenadines
- (Saint Vincent and The Grenadines)
- Samoa
- (Samoa)
- San Marino
- (San Marino)
- Sao Tome and Principe
- (Sao Tome and Principe)
- Saudi Arabia
- (Saudi Arabia)
- Scotland
- (Scotland)
- Senegal
- (Senegal)
- Serbia
- (Serbia)
- Seychelles
- (Seychelles)
- Sierra Leone
- (Sierra Leone)
- Singapore
- (Singapore)
- Slovakia (Slovak Republic)
- (Slovakia (Slovak Republic))
- Slovenia
- (Slovenia)
- Solomon Islands
- (Solomon Islands)
- Somalia
- (Somalia)
- South Africa
- (South Africa)
- Southern Territories, French
- (Southern Territories, French)
- Soviet Union (former)
- (Soviet Union (former))
- Spain
- (Spain)
- Sri Lanka
- (Sri Lanka)
- St. Helena, Ascension and Tristan da
- Cunha
- (St. Helena, Ascension and Tristan da
- Cunha)
- St. Pierre and Miquelon
- (St. Pierre and Miquelon)
- Sudan
- (Sudan)
- Sudan, South
- (Sudan, South)
- Suriname
- (Suriname)
- Svalbard and Jan Mayen Islands
- (Svalbard and Jan Mayen Islands)
- Swaziland
- (Swaziland)
- Sweden
- (Sweden)
- Switzerland
- (Switzerland)
- Syria
- (Syria)
- Taiwan
- (Taiwan)
- Tajikistan
- (Tajikistan)
- Tanzania
- (Tanzania)
- Thailand
- (Thailand)
- Togo
- (Togo)
- Tokelau
- (Tokelau)
- Tonga
- (Tonga)
- Trinidad and Tobago
- (Trinidad and Tobago)
- Tunisia
- (Tunisia)
- Turkey
- (Turkey)
- Turkmenistan
- (Turkmenistan)
- Turks and Caicos Islands
- (Turks and Caicos Islands)
- Tuvalu
- (Tuvalu)
- Uganda
- (Uganda)
- Ukraine
- (Ukraine)
- United Arab Emirates
- (United Arab Emirates)
- United Kingdom (Great Britain)
- (United Kingdom (Great Britain))
- United States
- (United States)
- Uruguay
- (Uruguay)
- US Minor Outlying Islands
- (US Minor Outlying Islands)
- Uzbekistan
- (Uzbekistan)
- Vanuatu
- (Vanuatu)
- Vatican City State (Holy See)
- (Vatican City State (Holy See))
- Venezuela
- (Venezuela)
- Viet Nam
- (Viet Nam)
- Virgin Islands (British)
- (Virgin Islands (British))
- Virgin Islands (US)
- (Virgin Islands (US))
- Wales
- (Wales)
- Wallis and Futuna Islands
- (Wallis and Futuna Islands)
- Western Sahara
- (Western Sahara)
- Yemen
- (Yemen)
- Yugoslavia
- (Yugoslavia)
- Zaire
- (Zaire)
- Zambia
- (Zambia)
- Zimbabwe
- (Zimbabwe)
Population: population the individual (or ancestors) belongs to; e.g. white, gypsy, Jewish-Ashkenazi, Africa-N, Sardinia, etc.
Age at death: age at which the individual deceased (when applicable):
- 35y = 35 years
- >43y = still alive at 43y
- 04y08m = 4 years and 8 months
- 00y00m01d12h = 1 day and 12 hours
- 18y? = around 18 years
- 30y-40y = between 30 and 40 years
- >54y = older than 54
- ? = unknown
VIP: individual/phenotype VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator.
NOTE: to get VIP status ask the curator.
Data_av: are additional data available upon request: e.g. pedigree (yes/no/?)
Treatment: treatment of patient
Variants in genes: The individual has variants for this gene.
Panel size: Number of individuals this entry represents; e.g. 1 for an individual, 5 for a family with 5 affected members.

 Individual ID
|

 ID_report
|

 Reference
|
 Remarks
|

 Gender
|

 Consanguinity
|

 Country
|

 Population
|

 Age at death
|

 VIP
|

 Data_av
|

 Treatment
|

 Disease
|

 Phenotype details
|

 Variants
|

 Panel size
|

 Owner
|
00100068 |
61076 |
PubMed: Li 2017 |
- |
F |
no |
Pakistan |
Pakistani |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
James Hejtmancik |
00100080 |
61120 |
PubMed: Li 2017 |
- |
M |
yes |
Pakistan |
Pakistani |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
James Hejtmancik |
00170851 |
IRD4.0_#21 |
Manuscript under review (González-del Pozo et al., 2018) |
- |
F |
yes |
Spain |
- |
- |
- |
- |
- |
LCA |
- |
1 |
1 |
María González-del Pozo |
00232606 |
- |
PubMed: Koyanagi 2019, Journal: Koyanagi 2019 |
analysis 1204 retinitis pigmentosa cases |
- |
- |
Japan |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
Yoshito Koyanagi |
00232607 |
- |
PubMed: Koyanagi 2019, Journal: Koyanagi 2019 |
analysis 1204 retinitis pigmentosa cases |
- |
- |
Japan |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
2 |
Yoshito Koyanagi |
00308613 |
- |
PubMed: Holtan 2020 |
1 homozygous patient |
- |
- |
Norway |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
Global Variome, with Curator vacancy |
00308614 |
- |
PubMed: Holtan 2020 |
1 homozygous patient |
- |
- |
Norway |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
Global Variome, with Curator vacancy |
00325423 |
1274 |
PubMed: Zenteno 2020 |
- |
- |
- |
Mexico |
- |
- |
- |
- |
- |
retinal disease |
Leber congenital amaurosis |
1 |
1 |
Johan den Dunnen |
00325487 |
3580 |
PubMed: Zenteno 2020 |
single patient |
- |
- |
Mexico |
- |
- |
- |
- |
- |
retinal disease |
retinitis pigmentosa |
1 |
1 |
Johan den Dunnen |
00332271 |
Fam19PatFBP_55 |
PubMed: Porto 2017 |
proband |
- |
- |
Brazil |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00359080 |
12004275 |
PubMed: Ellingford 2016 |
patient |
- |
- |
- |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00363699 |
12DG1182 |
PubMed: Patel 2016 |
- |
- |
- |
Saudi Arabia |
- |
- |
- |
- |
- |
retinal disease |
non-syndromic |
1 |
1 |
LOVD |
00373837 |
Rp1 |
PubMed: Zhao 2015 |
simplex case |
- |
- |
Northern Ireland |
- |
- |
- |
- |
- |
retinal disease |
see paper; ... |
2 |
1 |
LOVD |
00375332 |
K1153 |
PubMed: Oishi 2014 |
family |
- |
- |
Japan |
- |
- |
- |
- |
- |
retinal disease |
see paper; ... |
1 |
1 |
LOVD |
00376765 |
27 |
PubMed: Wang 2014 |
- |
F |
- |
United States |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00376772 |
36 |
PubMed: Wang 2014 |
- |
M |
- |
United States |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00376784 |
50 |
PubMed: Wang 2014 |
- |
M |
- |
United States |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00376855 |
Fam2 |
PubMed: Coppieters 2014 |
see paper |
- |
yes |
Turkey |
- |
- |
- |
- |
- |
retinal disease |
see paper; ... |
1 |
1 |
LOVD |
00377540 |
JU1039 |
PubMed: Hosono 2018 |
proband, family JIKEI-145 |
F |
no |
Japan |
Asian |
- |
- |
- |
- |
retinal disease |
see paper |
2 |
1 |
LOVD |
00377541 |
JU1040 |
PubMed: Hosono 2018 |
sister of JU1039, family JIKEI-145 |
F |
no |
Japan |
Asian |
- |
- |
- |
- |
retinal disease |
see paper |
2 |
1 |
LOVD |
00379379 |
- |
PubMed: Collin-2011 |
- |
F |
- |
Netherlands |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00379519 |
- |
PubMed: Littink-2012 |
- |
M |
- |
Netherlands |
- |
- |
- |
- |
- |
retinal disease |
Normal optic disc, slightly attenuated vasculature, absent foveolar reflex, irregular pigmentation with many small white dots in mid-periphery. |
1 |
1 |
LOVD |
00379520 |
- |
PubMed: Littink-2012 |
- |
M |
- |
Netherlands |
- |
- |
- |
- |
- |
retinal disease |
Pale optic disc, normal vasculature, small white dots and granular aspect in mid-periphery. |
1 |
1 |
LOVD |
00379521 |
- |
PubMed: Littink-2012 |
- |
M |
- |
Netherlands |
- |
- |
- |
- |
- |
retinal disease |
Normal optic disc, mildly attenuated vasculature, normal macula, in periphery white dots and granular appearance. |
1 |
1 |
LOVD |
00379522 |
- |
PubMed: Littink-2012 |
- |
M |
- |
Netherlands |
- |
- |
- |
- |
- |
retinal disease |
Normal optic disc, mildly attenuated vasculature, granular aspect of the macula, in periphery few white dots, granular appearance. |
1 |
1 |
LOVD |
00380129 |
11DG0632 |
PubMed: Patel 2018 |
- |
- |
yes |
Saudi Arabia |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00380133 |
12DG0405 |
PubMed: Patel 2018 |
- |
- |
likely |
Saudi Arabia |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00381191 |
- |
PubMed: Wang-2013 |
- |
- |
no |
- |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
Julia Lopez |
00381212 |
- |
PubMed: Wang-2013 |
novel LOF mutations |
- |
no |
- |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
Julia Lopez |
00381643 |
- |
PubMed: Eisenberger-2013 |
- |
M |
yes |
Saudi Arabia |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00381644 |
- |
PubMed: Eisenberger-2013 |
- |
F |
yes |
Turkey |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00382560 |
422 |
PubMed: Jespersgaar 2019 |
- |
? |
- |
Denmark |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00382636 |
D (II:1) |
PubMed: Gonzalez del Pozo 2018 |
- |
? |
yes |
Spain |
- |
- |
- |
- |
- |
retinal disease |
additional photophobia; consang. |
1 |
1 |
LOVD |
00382799 |
- |
PubMed: Song-2011 |
- |
F |
- |
- |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00383067 |
- |
PubMed: Anasagasti-2013 |
- |
- |
- |
Spain |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00383923 |
RP-0479 |
PubMed: Martin Merida 2019 |
- |
? |
- |
Spain |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00384192 |
066852 |
PubMed: Tayebi 2019 |
- |
- |
- |
Iran |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00384193 |
066853 |
PubMed: Tayebi 2019 |
- |
- |
- |
Iran |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00389509 |
793 |
PubMed: Weisschuh 2020 |
Filing key number: 312, autosomal recessive retinitis pigmentosa, no patient Ids, consecutive numbers given |
M |
- |
Germany |
- |
- |
- |
- |
- |
retinal disease |
age at genetic diagnosis mentioned |
1 |
1 |
LOVD |
00389848 |
1132 |
PubMed: Weisschuh 2020 |
Filing key number: 780, sporadic retinitis pigmentosa, no patient Ids, consecutive numbers given |
F |
- |
Germany |
- |
- |
- |
- |
- |
retinal disease |
age at genetic diagnosis mentioned |
1 |
1 |
LOVD |
00391659 |
55 |
PubMed: Sallum 2020 |
- |
? |
- |
Brazil |
- |
- |
- |
- |
- |
retinal disease |
best corrected visual acuity right/left eye: 20/200;20/100 |
1 |
1 |
LOVD |
00391660 |
56 |
PubMed: Sallum 2020 |
- |
? |
- |
Brazil |
- |
- |
- |
- |
- |
retinal disease |
best corrected visual acuity right/left eye: 20/80:20/80 |
2 |
1 |
LOVD |
00391661 |
57 |
PubMed: Sallum 2020 |
- |
? |
- |
Brazil |
- |
- |
- |
- |
- |
retinal disease |
best corrected visual acuity right/left eye: 20/1600;20/1600 |
1 |
1 |
LOVD |
00391662 |
58 |
PubMed: Sallum 2020 |
- |
? |
- |
Brazil |
- |
- |
- |
- |
- |
retinal disease |
best corrected visual acuity right/left eye: 20/100;20/60 |
1 |
1 |
LOVD |
00391663 |
59 |
PubMed: Sallum 2020 |
- |
? |
- |
Brazil |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00391664 |
60 |
PubMed: Sallum 2020 |
- |
? |
- |
Brazil |
- |
- |
- |
- |
- |
retinal disease |
best corrected visual acuity right/left eye: 20/320;20/320 |
1 |
1 |
LOVD |
00391729 |
116 |
PubMed: Sallum 2020 |
- |
? |
- |
Brazil |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00396209 |
- |
PubMed: SkorczykWerner 2020 |
- |
F |
- |
- |
Polish |
- |
- |
- |
- |
retinal disease |
1 month: nystagmus the oculo-digital sign |
1 |
1 |
LOVD |
00406595 |
293_1 |
PubMed: Preising 2007 |
family 293, individual 1 |
? |
- |
- |
- |
- |
- |
- |
- |
retinal disease |
- |
2 |
1 |
LOVD |
00409869 |
1 |
PubMed: Borman 2012 |
- |
M |
yes |
- |
South-east Asian |
- |
- |
- |
- |
retinal disease |
nyctalopia, visual field constriction, reduced vision, photophilia, poor color vision, prolonged photopic to mesopic adaptation; best corrected visual acuity right/left eye: 0.22/0.90; electroretinography (pattern): some bilateral macular preservation, full-field: undetectable |
1 |
1 |
LOVD |
00409870 |
2 |
PubMed: Borman 2012 |
- |
F |
yes |
- |
white |
- |
- |
- |
- |
retinal disease |
nyctalopia, visual field constriction, reduced vision, no photophilia, poor color vision, prolonged photopic to mesopic adaptation; best corrected visual acuity right/left eye: 0.66/hand movement; electroretinography (pattern): severe bilateral macular dysfunction, full-field: undetectable |
1 |
1 |
LOVD |
00409871 |
3 |
PubMed: Borman 2012 |
- |
M |
no |
- |
white |
- |
- |
- |
- |
retinal disease |
nyctalopia, visual field constriction, reduced vision, photophilia, poor color vision, prolonged photopic to mesopic adaptation; best corrected visual acuity right/left eye: hand movement/1.80; electroretinography (pattern): severe bilateral macular dysfunction, full-field: severe photoreceptor dysfunction |
1 |
1 |
LOVD |
00409872 |
4 |
PubMed: Borman 2012 |
- |
F |
no |
- |
Caribbean |
- |
- |
- |
- |
retinal disease |
nyctalopia, visual field constriction, reduced vision, photophilia, poor color vision; best corrected visual acuity right/left eye: 0.80/0.50; electroretinography (pattern): not available, full-field: not available |
1 |
1 |
LOVD |
00409873 |
arRP186 |
PubMed: Thompson 2001 |
- |
F |
yes |
- |
- |
- |
- |
- |
- |
retinal disease |
visual field of less than 5 degrees |
1 |
1 |
LOVD |
00409874 |
arRP824 |
PubMed: Thompson 2001 |
- |
F |
yes |
- |
- |
- |
- |
- |
- |
retinal disease |
visual field restricted to tiny central islands; funduscopy: optic disc pallor, attenuated retinal arterioles, peripheral RPE atrophy and perimacular retinal surface wrinkling but little bone-spicule pigment |
1 |
1 |
LOVD |
00409875 |
2910 |
PubMed: Thompson 2001 |
- |
M |
no |
- |
- |
- |
- |
- |
- |
retinal disease |
no electroretinogram responses at age 15; currently, no central vision |
1 |
1 |
LOVD |
00409876 |
1 |
PubMed: Senechal 2006 |
- |
F |
- |
- |
- |
- |
- |
- |
- |
retinal disease |
mild form of typical retinitis pigmentosa; peripheral visual field loss >60y |
1 |
1 |
LOVD |
00409877 |
2 |
PubMed: Senechal 2006 |
- |
M |
yes |
- |
- |
- |
- |
- |
- |
retinal disease |
did not follow objects at age 2.5 months, but saw lights; had no nystagmus, deeply night blindness; progressively improved so that he recognized various objects (cars, forks) and could move by himself in a bright environment at age 21 months; hyperopaia with refraction right/left eye: +4.25 (-0.50; 30deg) / +4.50 (-0.75; 165deg); subnormal binocular visual acuity (2.5/10) at the baby vision test; fundus: normal-looking maculae with good reflexes and normal optic disks; no pigment deposits either in the posterior pole or in periphery, retinal vessels were slightly narrowed, no depigmentation spots or flecks; electroretinogram: flat for all types of stimulation |
1 |
1 |
LOVD |
00409878 |
? |
PubMed: Bussieres 2007 |
cell line investigation (HEK cells) |
- |
- |
- |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00409879 |
110 |
PubMed: Scholl 2015 |
M |
- |
- |
- |
- |
- |
- |
- |
daily oral dose of 40 mg/m2/day 9-cis-retinyl acetate (QLT091001) |
retinal disease |
baseline visual acuity (ETDRS Letter Score) right/left eye: 70.5/59.5; visual acuity response (ETDRS Letter Score, defined as improvement in logMAR (>=5 letter score, or from 0 to seeing any letters) on at least 2 consecutive visits starting) right/left eye: 8.9/10.5; baseline Goldmann visual field, retinal area (mm2) right/left eye: 42/17; Goldmann visual field, response percent (defined as improvements in GVF retinal area 20% on at least 2 consecutive visits starting by Month 2) right/left eye:0.68/3.31 |
1 |
1 |
LOVD |
00409880 |
111 |
PubMed: Scholl 2015 |
M |
- |
- |
- |
- |
- |
- |
- |
daily oral dose of 40 mg/m2/day 9-cis-retinyl acetate (QLT091001) |
retinal disease |
baseline visual acuity (ETDRS Letter Score) right/left eye: 0/1.5; visual acuity response (ETDRS Letter Score, defined as improvement in logMAR (>=5 letter score, or from 0 to seeing any letters) on at least 2 consecutive visits starting) right/left eye: no/16; baseline Goldmann visual field, retinal area (mm2) right/left eye: 288/288; Goldmann visual field, response percent (defined as improvements in GVF retinal area 20% on at least 2 consecutive visits starting by Month 2) right/left eye:no/no |
1 |
1 |
LOVD |
00409881 |
117 |
PubMed: Scholl 2015 |
M |
- |
- |
- |
- |
- |
- |
- |
daily oral dose of 40 mg/m2/day 9-cis-retinyl acetate (QLT091001) |
retinal disease |
baseline visual acuity (ETDRS Letter Score) right/left eye: 37/39.5; visual acuity response (ETDRS Letter Score, defined as improvement in logMAR (>=5 letter score, or from 0 to seeing any letters) on at least 2 consecutive visits starting) right/left eye: 14.2/11.8; baseline Goldmann visual field, retinal area (mm2) right/left eye: 263/251; Goldmann visual field, response percent (defined as improvements in GVF retinal area 20% on at least 2 consecutive visits starting by Month 2) right/left eye:0.52/0.42 |
1 |
1 |
LOVD |
00409884 |
202 |
PubMed: Scholl 2015 |
F |
- |
- |
- |
- |
- |
- |
- |
daily oral dose of 40 mg/m2/day 9-cis-retinyl acetate (QLT091001) |
retinal disease |
baseline visual acuity (ETDRS Letter Score) right/left eye: 60.5/40; visual acuity response (ETDRS Letter Score, defined as improvement in logMAR (>=5 letter score, or from 0 to seeing any letters) on at least 2 consecutive visits starting) right/left eye: no/9.5; baseline Goldmann visual field, retinal area (mm2) right/left eye: 34/25; Goldmann visual field, response percent (defined as improvements in GVF retinal area 20% on at least 2 consecutive visits starting by Month 2) right/left eye:no/no |
1 |
1 |
LOVD |
00409886 |
302 |
PubMed: Scholl 2015 |
F |
- |
- |
- |
- |
- |
- |
- |
daily oral dose of 40 mg/m2/day 9-cis-retinyl acetate (QLT091001) |
retinal disease |
baseline visual acuity (ETDRS Letter Score) right/left eye: 53/27.5; visual acuity response (ETDRS Letter Score, defined as improvement in logMAR (>=5 letter score, or from 0 to seeing any letters) on at least 2 consecutive visits starting) right/left eye: no/no; baseline Goldmann visual field, retinal area (mm2) right/left eye: 145/120; Goldmann visual field, response percent (defined as improvements in GVF retinal area 20% on at least 2 consecutive visits starting by Month 2) right/left eye: no/no |
1 |
1 |
LOVD |
00409897 |
fam61254pat7 |
PubMed: Chen 2018 |
family 61254 |
M |
yes |
Pakistan |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00409898 |
fam61254pat8 |
PubMed: Chen 2018 |
family 61254 |
M |
yes |
Pakistan |
- |
- |
- |
- |
- |
retinal disease |
waxy pale optic discs, attenuation of retinal arteries, bone spicule-like pigment deposits in the midperiphery of the retina, and macular changes |
1 |
1 |
LOVD |
00409899 |
fam61254pat32 |
PubMed: Chen 2018 |
family 61254 |
M |
yes |
Pakistan |
- |
- |
- |
- |
- |
retinal disease |
attenuation of retinal arteries; extinguished electroretinogram |
1 |
1 |
LOVD |
00409900 |
fam61254pat33 |
PubMed: Chen 2018 |
family 61254 |
F |
yes |
Pakistan |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00409901 |
fam61254pat42 |
PubMed: Chen 2018 |
family 61254 |
F |
yes |
Pakistan |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00409902 |
fam61254pat43 |
PubMed: Chen 2018 |
family 61254 |
F |
yes |
Pakistan |
- |
- |
- |
- |
- |
retinal disease |
- |
1 |
1 |
LOVD |
00409929 |
I |
PubMed: Talib 2019 |
sibling of II |
M |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in 1st decade of life; visual field loss: 3rd decade of life; visual acuity loss: 2nd decade of life; best corrected visual acuity: counting fingers; macula: profound chorioretinal and retinal pigment epithelium atrophy, sharply demarcated. pigment clumping.; age at visual field testing: 23y - central horizontal diameter V-4e (deg): 1.5/2; central horizontal diameter I-4e (deg): 0/0; minimal isopter size observed on Goldmann kinetic perimetry: III-4e; seeing retinal area V4e (mm2): not available/679.1; pattern: absolute central scotoma. peripheral wedge of vision. 50y - central horizontal diameter V-4e (deg): 0/0; central horizontal diameter I-4e (deg): 0/0; minimal isopter size observed on Goldmann kinetic perimetry: I-4e; seeing retinal area V4e (mm2): 213.6/234.6; pattern: large absolute central scotoma with small island of foveal sparing. midperipheral remaining ring.; change (mm2/year):-16.8 |
1 |
1 |
LOVD |
00409930 |
II |
PubMed: Talib 2019 |
sibling of I |
M |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: 1st decade of life; visual acuity loss: 1st decade of life; best corrected visual acuity: counting fingers; macula: sheen, retinal pigment epithelium alterations; age at visual field testing: 29y - central horizontal diameter V-4e (deg): 73/63; central horizontal diameter I-4e (deg): 0/0; minimal isopter size observed on Goldmann kinetic perimetry: I-3e; seeing retinal area V4e (mm2): 768.3/725.7; pattern: relative central scotoma (���i4e). absolute paracentral s |
1 |
1 |
LOVD |
00409931 |
III |
PubMed: Talib 2019 |
- |
F |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: 3rd decade of life; visual acuity loss: 3rd decade of life; best corrected visual acuity: 20/200; macula: retinal and retinal pigment epithelium atrophy; age at visual field testing: 30y - central horizontal diameter V-4e (deg): not available/; central horizontal diameter I-4e (deg): not available/; minimal isopter size observed on Goldmann kinetic perimetry: not available; seeing retinal area V4e (mm2): not available/; pattern: supra-temporal absolute scotoma; relative central scotoma |
1 |
1 |
LOVD |
00409932 |
IV |
PubMed: Talib 2019 |
- |
M |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: 3rd decade of life; visual acuity loss: 2nd decade of life; best corrected visual acuity: counting fingers; macula: retinal pigment epithelium alterations, choroidal atrophy |
1 |
1 |
LOVD |
00409933 |
V |
PubMed: Talib 2019 |
- |
F |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: 2nd decade of life; visual acuity loss: 2nd/3rd decade of life; best corrected visual acuity: counting fingers; macula: sheen, retinal pigment epithelium atrophic alterations |
1 |
1 |
LOVD |
00409934 |
VI |
PubMed: Talib 2019 |
- |
M |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: 3rd decade of life; visual acuity loss: 2nd decade of life; best corrected visual acuity: 20/200; macula: chorioretinal and retinal pigment epithelium atrophy spanning posterior pole and beyond vascular arcade |
1 |
1 |
LOVD |
00409935 |
VII |
PubMed: Talib 2019 |
- |
F |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: 3rd decade of life; visual acuity loss: before 4th decade of life; best corrected visual acuity: 20/100; macula: difficult to assess due to synchysis scintillans. small pigmentations; age at visual field testing: 37y - central horizontal diameter V-4e (deg): 145/142; central horizontal diameter I-4e (deg): 48-10/53; minimal isopter size observed on Goldmann kinetic perimetry: I-2e; seeing retinal area V4e (mm2): 782.8/765.7; change (mm2/year):-15.4; pattern: midperipheral absolute scotomas, encroaching towards fovea. relative concentric constriction.52y - central horizontal diameter V-4e (deg): 72/66; central horizontal diameter I-4e (deg): 39-10/55; minimal isopter size observed on Goldmann kinetic perimetry: I-2e; seeing retinal area V4e (mm2): 543.9/543.5; pattern: relative paracentral scotomas. relative concentric constriction, mainly superior hemifield. |
1 |
1 |
LOVD |
00409936 |
VIII |
PubMed: Talib 2019 |
- |
M |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in 1st decade of life; visual field loss: before 5th decade of life; visual acuity loss: 1st decade of life; best corrected visual acuity: 20/25; macula: sheen, retinal pigment epithelium atrophy around spared fovea; age at visual field testing: 48y - central horizontal diameter V-4e (deg): 153/98; central horizontal diameter I-4e (deg): 44650/11; minimal isopter size observed on Goldmann kinetic perimetry: I-3e; seeing retinal area V4e (mm2): 707.1/691.9; pattern: absolute midperipheral and paracentral scotomas. |
1 |
1 |
LOVD |
00409937 |
IX |
PubMed: Talib 2019 |
- |
M |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in 1st decade of life; visual field loss: 1st decade of life; visual acuity loss: ; best corrected visual acuity: 20/20; macula: sheen, normal pigmentation, white dots; age at visual field testing: 11y - central horizontal diameter V-4e (deg): not available (only a description of the visual field in the medical record)/; central horizontal diameter I-4e (deg): not available (only a description of the visual field in the medical record)/; minimal isopter size observed on Goldmann kinetic perimetry: not available (only a description of the visual field in the medical record); seeing retinal area V4e (mm2): not available (only a description of the visual field in the medical record)/; pattern: multiple relative scotomas in periphery. |
1 |
1 |
LOVD |
00409938 |
X |
PubMed: Talib 2019 |
- |
F |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in 1st decade of life; visual field loss: 2nd decade of life; visual acuity loss: 2nd decade of life; best corrected visual acuity: 20/20; macula: no sheen, subtle white dots on a pale retina, subtle granular retinal pigment epithelium changes.; age at visual field testing: 40y - central horizontal diameter V-4e (deg): not available (only a description of the visual field in the medical record)/; central horizontal diameter I-4e (deg): not available (only a description of the visual field in the medical record)/; minimal isopter size observed on Goldmann kinetic perimetry: not available (only a description of the visual field in the medical record); seeing retinal area V4e (mm2): not available (only a description of the visual field in the medical record)/; pattern: absolute concentric constriction, 20deg from fovea |
1 |
1 |
LOVD |
00409939 |
XI |
PubMed: Talib 2019 |
- |
F |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: 5th decade of life; visual acuity loss: 1st decade of life; best corrected visual acuity: 20/40; macula: atrophic retinal pigment epithelium alterations; age at visual field testing: 38y - central horizontal diameter V-4e (deg): 140/150; central horizontal diameter I-4e (deg): 75/77; minimal isopter size observed on Goldmann kinetic perimetry: I-3e; seeing retinal area V4e (mm2): 718.9/736.2; pattern: absolute concentric constriction. 39y - central horizontal diameter V-4e (deg): 130/140; central horizontal diameter I-4e (deg): 73/70; minimal isopter size observed on Goldmann kinetic perimetry: I-3e; seeing retinal area V4e (mm2): 700.6/716.2; pattern: absolute concentric constriction. ; change (mm2/year):-13.4 |
1 |
1 |
LOVD |
00409940 |
XII |
PubMed: Talib 2019 |
- |
F |
- |
- |
Dutch |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: not available; visual acuity loss: not available; best corrected visual acuity: 20/16; macula: retinal pigment epithelium alterations; age at visual field testing: 54y - central horizontal diameter V-4e (deg)NAd/; central horizontal diameter I-4e (deg): NAd/; minimal isopter size observed on Goldmann kinetic perimetry: NAd; seeing retinal area V4e (mm2): NAd/ |
1 |
1 |
LOVD |
00409941 |
XIII |
PubMed: Talib 2019 |
- |
M |
- |
- |
Turkish-Belgian |
- |
- |
- |
- |
retinal disease |
nyctalopia in infancy; visual field loss: 2nd decade of life; visual acuity loss: 1st decade of life; best corrected visual acuity: 20/66; macula: central macula with normal appearance, white dots in the superior posterior pole. ; age at visual field testing: 15y - central horizontal diameter V-4e (deg): 116/130; central horizontal diameter I-4e (deg): 4/2; minimal isopter size observed on Goldmann kinetic perimetry: I4e; seeing retinal area V4e (mm2): 452.2/512; pattern: absolute concentric constriction.16y - central horizontal diameter V-4e (deg): 116/128; central horizontal diameter I-4e (deg): 0/2; minimal isopter size observed on Goldmann kinetic perimetry: II4e/ I4e; seeing retinal area V4e (mm2): 455.6/507.2; pattern: increased concentric constriction.17y - central horizontal diameter V-4e (deg): 134/123; central horizontal diameter I-4e (deg): 0/3; minimal isopter size observed on Goldmann kinetic perimetry: II4e/ I4e; seeing retinal area V4e (mm2): 562.5/530; pattern: absolute concentric constriction.; change (mm2/year):41.9 |
1 |
1 |
LOVD |
00447555 |
LCA-156 |
PubMed: Weisschuh 2024 |
patient, no family history |
F |
- |
Germany |
- |
- |
- |
- |
- |
? |
- |
1 |
1 |
Johan den Dunnen |